Staying up-to-date has never been simpler. Sign up for the free GenePool newsletter today!
Santarus, Inc. (NASDAQ: SNTS), a specialty biopharmaceutical company, today reported financial and operating results for the quarter ended March 31, 2013.
Key financial results for the 2013 first quarter include:
•Total revenues of $79.4 million grew 73% compared with total revenues of $45.9 million in the first quarter of 2012
Help employers find you! Check out all the jobs and post your resume.
